To access this element change to forms mode OFF
Grant Award View - GA29981
Re-engineering synthetic receptors for improved cancer immunotherapies
GA ID:
GA29981
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$794,773.15
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Re-engineering synthetic receptors for improved cancer immunotherapies
Purpose:
Chimeric antigen receptors (CARs) are engineered immune sensors that redirect a patient’s killer immune cells to eliminate tumours. This technology has seen great success in some blood cancers, but its broader application requires a new generation of CAR designs that can provide more predictable control of immune activation. This project applies computational design and structural biology approaches to generate tools that will provide a new and powerful level of control over CAR activity.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1158249
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, ISRAEL